It is currently Tue May 03, 2016 5:14 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

a little history of nearly everything by Bill Bryson

good read very interesting.
Read more : a little history of nearly everything by Bill Bryson | Views : 3025 | Replies : 1 | Forum : Reading Nook


Have a date... (but nowhere to stay)

So, with probably too much persistence, I have my date! (I feel like I'm going to the prom all over again! LOL)

I will be going back to Baltimore on June 30th.

I was hoping to stay at the spinnaker bay - but they seem to be booked and I can not confirm my spot there....both Chase Street and Bridge Street have no availability in their properties... so now I'm a little frantic (okay, not ...
Read more : Have a date... (but nowhere to stay) | Views : 1933 | Replies : 3 | Forum : Revimmune (cyclophosphamide or cytoxan)


New Site

I am going to be posting a comment I got on the last post I did from a girl named Kathy from my site.

She is going to Rush at the end of the month to start HiCy.

If you want to read it exactly go there...she is the second comment on the latest blog post after the a-hole spammers took over.

So there you have a second place who is starting for sure.
Read more : New Site | Views : 2408 | Replies : 8 | Forum : Revimmune (cyclophosphamide or cytoxan)


Results of ASCT trial

Autologous Haematopoietic Stem Cell Transplantation After Immunosuppressive Therapy Effective and Safe in Multiple Sclerosis
12 June 2008

In patients with multiple sclerosis (MS), immunosuppressive therapy followed by autologous haematopoietic stem cell transplantation elicited high response rates and improved quality of life for up to 6 years.

The results of the study were presented here at the 18th Meeting of the European Neurological Society (ENS) by Tatiana Ionova, MD, PhD, Department of Haematology, Pirogov National ...
Read more : Results of ASCT trial | Views : 1670 | Replies : 1 | Forum : Drug Pipeline




fed up

okay any of you caregivers out there get really fed up with a sad sack of a sick person? if so how do you deal? because i fail to handle an ongoing whiny irritable fatalistic attitude - clearly, so not my style. any tips appreciated. it's not like it's a few days, i have reached the end of my tether after months and months and it's getting worse not better. doctor says all we can ...
Read more : fed up | Views : 3859 | Replies : 17 | Forum : Daily Life


Useful website: Quackwatch

I just wanted to make sure psople were aware of this extremely useful site

http://www.quackwatch.org/index.html

I would highly recommend using it as a "filter" to protect yourself from being scammed.

Take care.
Read more : Useful website: Quackwatch | Views : 1775 | Replies : 3 | Forum : Natural Approach


Rehab

No, not that kind of rehab...

Effectiveness of Rehabilitation Intervention in persons with Multiple sclerosis: A Randomized Controlled Trial.

J Neurol Neurosurg Psychiatry. 2008 Jun 5.
Khan F, Pallant JF, Brand C, Kilpatrick TJ.
Deaprtment of rehabilitation Medicine, University of Melbourne, Australia.

OBJECTIVE: A stratified, randomized, waitlist controlled study over 12 months assessed the effectiveness of rehabilitation in persons with Multiple Sclerosis (MS) in an Australian community cohort.

METHODS: Patients with definite MS (n=101) recruited ...
Read more : Rehab | Views : 1150 | Replies : 0 | Forum : General Discussion


Esperanza Peptide anybody

Hi, I am just wondering of anybody is using or has considered using Esperanza Petide. They claim all sorts of benefits ofcourse but is it worth its money ? :wink:
Read more : Esperanza Peptide anybody | Views : 2505 | Replies : 5 | Forum : Natural Approach


Tovaxin results

I hope this hasn't already been posted!

Favourable Two-Year Data in Phase I/II Retreatment Studies of Tovaxin® for Multiple Sclerosis 12 June 2008

Opexa Therapeutics, Inc. announced favourable safety and efficacy data for Tovaxin®, the Company’s investigational T-cell vaccination therapy for multiple sclerosis (MS), in the second year of open-label clinical retreatment studies in patients with MS.
The “intent to treat” population of 22 patients included 13 with relapsing remitting multiple sclerosis (RRMS) and ...
Read more : Tovaxin results | Views : 1827 | Replies : 0 | Forum : Tcelna (Tovaxin)


 

Login  •  Register


Statistics

Total posts 232086 • Total topics 24792 • Total members 15957


Contact us | Terms of Service